California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin ...

An elderly diabetic man died after insulin was repeatedly given to him after eating, instead of before, by nurses at ...

NAD+ boosters can affect how certain medications like insulin, blood pressure lowering, antidepressants, and cancer ...

An executive order by Trump rolled back some efforts by the Biden administration to control Medicare costs but it didn't ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

Hims & Hers' lower-priced injectable semaglutide promoted during the Super Bowl has led to some patients receiving the more ...

President and CEO Ned McCoy shared with Becker's some of the company's key objectives for the year, including the launch of some of the first medications from its Petersburg, Va.-based plant, the ...

Two years ago, California made a bold announcement that it would manufacture a state-branded, low-cost insulin. Drug manufacturers, insurers, economists and diabetics took notice. It had the ...

It had the potential to disrupt the market, bring down drug costs and save patients’ lives. Gov. Gavin Newsom promised a “2024 delivery” for the insulin. It still is not here, and the ...